Subscribe for $2

Subscribe for 2 $

Caladrius Biosciences Aktie News & Pressemeldungen

Caladrius Biosciences Eulerpool News

Caladrius Biosciences Eulerpool News

Caladrius Biosciences Stock News

Caladrius Biosciences is being monitored by journalists and investors worldwide. We gather the latest Caladrius Biosciences news here.

September 14 ·
Thefly.com
Caladrius announces approval of merger, name change to Lisata Therapeutics
September 12 ·
Yahoo
Life Sciences Virtual Investor Conference Agenda Announced for September 15th
September 8 ·
Yahoo
Caladrius Biosciences Announces Participation in Upcoming Investor Conferences in September 2022
September 2 ·
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
August 10 ·
Yahoo
Caladrius Biosciences’ Prospective Merger Partner, Cend Therapeutics, Announces Collaboration Agreement with Roche to Evaluate CEND-1 in Combination with Immunotherapy to Treat Pancreatic Cancer
August 10 ·
TipRanks
Analysts Conflicted on These Healthcare Names: Haemonetics (HAE), Caladrius Biosciences (CLBS) and Adicet Bio (ACET)
August 10 ·
Thefly.com
Caladrius announces Cend's agreement with F. Hoffmann-La Roche
August 7 ·
TipRanks
Dawson James Sticks to Its Hold Rating for Caladrius Biosciences (CLBS)
August 5 ·
TipRanks
H.C. Wainwright Thinks Caladrius Biosciencesâ Stock is Going to Recover
August 5 ·
SeekingAlpha
Caladrius Biosciences, Inc. (CLBS) CEO David Mazzo on Q2 2022 Results - Earnings Call Transcript

1

2

1

2

Caladrius Biosciences Stock Press Releases

Caladrius Biosciences regularly publishes news on the company's website that are relevant for investors.

Own the gold standard ✨ in financial data & analytics
20 million companies worldwide · 50 year history · 10 year estimates · leading global news coverage

Subscribe for $2